0001140361-22-002458.txt : 20220124
0001140361-22-002458.hdr.sgml : 20220124
20220124114843
ACCESSION NUMBER: 0001140361-22-002458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220120
FILED AS OF DATE: 20220124
DATE AS OF CHANGE: 20220124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Busch Andreas
CENTRAL INDEX KEY: 0001775029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38787
FILM NUMBER: 22548098
MAIL ADDRESS:
STREET 1: C/O CYCLERION THERAPEUTICS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001755237
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831895370
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
form4.xml
FORM 4
X0306
4
2022-01-20
0001755237
Cyclerion Therapeutics, Inc.
CYCN
0001775029
Busch Andreas
C/O CYCLERION THERAPEUTICS, INC.
245 FIRST STREET, 18TH FLOOR
CAMBRIDGE
MA
02142
true
Chief Scientific Officer
Employee Stock Option (Right to Buy)
1.21
2022-01-20
4
A
0
135000
0
A
2032-01-20
Common Stock
135000
135000
D
The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022.
/s/ Gary J. Simon, Attorney-in-Fact
2022-01-24